EZBrisk / Market Verdict

EMR beats, falls

Emerson beat quarterly EPS and revenue, expanded margins, bought back stock and raised its dividend, but shares fell violently after hours as initial fiscal 2027 EPS guidance likely disappointed despite management citing accelerating software and systems demand.

Sources: https://ir.emerson.com/news-events/press-releases/detail/649/emerson-reports-fourth-qua

Previous verdicts for EMR

Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works

Open the live Ezbrisk dashboard Browse the archive